Abstract
The aim of this chapter will be to focus on the patient with third mobile window syndrome who also appears to have concomitant hydrops or has hydropic features after successful surgery repair. Research on MRI findings of hydrops in superior canal dehiscence patients will be discussed, and the treatment options available to patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- EH:
-
Endolymphatic hydrops
- EVA:
-
Enlarged vestibular aqueduct
- GD:
-
Gadolinium
- MD:
-
Ménière’s disease
- MRI:
-
Magnetic resonance imaging
- SNHL:
-
Sensorineural hearing loss
- SSCD:
-
Superior semicircular canal dehiscence
- TWS:
-
Third window syndrome
- VEMPs:
-
Vestibular evoked myogenic potentials
References
Gürkov R, Pyykö I, Zou J, Kentala E. What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops. J Neurol. 2016;263(Suppl 1):S71–81. Epub 2016 Apr 15. PMID: 27083887; PMCID: PMC4833790. https://doi.org/10.1007/s00415-015-7930-1.
Morita N, Kariya S, Farajzadeh Deroee A, Cureoglu S, Nomiya S, Nomiya R, Harada T, Paparella MM. Membranous labyrinth volumes in normal ears and Ménière disease: a three-dimensional reconstruction study. Laryngoscope. 2009;119(11):2216–20. PMID: 19806642; PMCID: PMC2927481. https://doi.org/10.1002/lary.20723.
Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol. 2005;26(1):74–81. PMID: 15699723. https://doi.org/10.1097/00129492-200501000-00013.
Pyykkö I, Nakashima T, Yoshida T, Zou J, Naganawa S. Meniere’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open. 2013;3(2):e001555. PMID: 23418296; PMCID: PMC3586172. https://doi.org/10.1136/bmjopen-2012-001555.
Takeda T, Takeda S, Kakigi A. A possible mechanism of the formation of endolymphatic hydrops and its associated inner ear disorders. Auris Nasus Larynx. 2020;47(1):25–41. Epub 2019 Oct 15. PMID: 31623941. https://doi.org/10.1016/j.anl.2019.09.005.
Gallego-Martinez A, Lopez-Escamez JA. Genetic architecture of Meniere’s disease. Hear Res. 2020;397:107872. Epub 2019 Dec 13. PMID: 31874721. https://doi.org/10.1016/j.heares.2019.107872.
Simo H, Yang S, Qu W, Preis M, Nazzal M, Baugh R. Meniere’s disease: importance of socioeconomic and environmental factors. Am J Otolaryngol. 2015;36(3):393–8. Epub 2015 Feb 3. PMID: 25771842. https://doi.org/10.1016/j.amjoto.2015.01.009.
Derebery MJ. Allergic and immunologic features of Ménière’s disease. Otolaryngol Clin North Am. 2011;44(3):655–66, ix. Epub 2011 May 4. PMID: 21621052. https://doi.org/10.1016/j.otc.2011.03.004.
Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A, Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS); Korean Balance Society. Diagnostic criteria for Menière’s disease. J Vestib Res. 2015;25(1):1–7. PMID: 25882471. https://doi.org/10.3233/VES-150549.
Iversen MM, Rabbitt RD. Biomechanics of third window syndrome. Front Neurol. 2020;11:891. PMID: 32982922; PMCID: PMC7477384. https://doi.org/10.3389/fneur.2020.00891.
Minor LB, Solomon D, Zinreich JS, Zee DS. Sound- and/or pressure-induced vertigo due to bone dehiscence of the superior semicircular canal. Arch Otolaryngol Head Neck Surg. 1998;124(3):249–58. PMID: 9525507. https://doi.org/10.1001/archotol.124.3.249.
Wackym PA, Agrawal Y, Ikezono T, Balaban CD. Editorial: Third window syndrome. Front Neurol. 2021;12:704095. Published 2021 Jun 18. https://doi.org/10.3389/fneur.2021.704095.
Ray A, Hautefort C, Guichard JP, Horion J, Herman P, Kania R, Houdart E, Verillaud B, Vitaux H, Attyé A, Eliezer M. MRI contribution for the detection of endolymphatic hydrops in patients with superior canal dehiscence syndrome. Eur Arch Otorhinolaryngol. 2021;278(7):2229–38. Epub 2020 Aug 14. PMID: 32797276. https://doi.org/10.1007/s00405-020-06282-3.
Sone M, Yoshida T, Morimoto K, Teranishi M, Nakashima T, Naganawa S. Endolymphatic hydrops in superior canal dehiscence and large vestibular aqueduct syndromes. Laryngoscope. 2016;126(6):1446–50. Epub 2015 Nov 3. PMID: 26525170. https://doi.org/10.1002/lary.25747.
Johanis M, De Jong R, Miao T, Hwang L, Lum M, Kaur T, Willis S, Arsenault JJ, Duong C, Yang I, Gopen Q. Concurrent superior semicircular canal dehiscence and endolymphatic hydrops: a novel case series. Int J Surg Case Rep. 2021;78:382–6. Epub 2020 Dec 26. PMID: 33421957; PMCID: PMC7804363. https://doi.org/10.1016/j.ijscr.2020.12.074.
Spiegel JH, Lalwani AK. Large vestibular aqueduct syndrome and endolymphatic hydrops: two presentations of a common primary inner-ear dysfunction? J Laryngol Otol. 2009;123(8):919–21. Epub 2008 Nov 12. PMID: 19000343. https://doi.org/10.1017/S0022215108004088.
Wang F, Yoshida T, Sugimoto S, Shimono M, Teranishi M, Naganawa S, Sone M. Clinical features of ears with otosclerosis and endolymphatic hydrops. Otol Neurotol. 2019;40(4):441–5. PMID: 30870351. https://doi.org/10.1097/MAO.0000000000002175.
Mukaida T, Sone M, Yoshida T, Kato K, Teranishi M, Naganawa S, Nakashima T. Magnetic resonance imaging evaluation of endolymphatic hydrops in cases with otosclerosis. Otol Neurotol. 2015;36(7):1146–50. PMID: 25522197. https://doi.org/10.1097/MAO.0000000000000685.
Shea JJ Jr, Ge X, Orchik DJ. Endolymphatic hydrops associated with otosclerosis. Am J Otol. 1994;15(3):348–57. PMID: 8579139.
Pisano DV, Niesten ME, Merchant SN, Nakajima HH. The effect of superior semicircular canal dehiscence on intracochlear sound pressures. Audiol Neurootol. 2012;17(5):338–48. Epub 2012 Jul 18. PMID: 22814034; PMCID: PMC3541532. https://doi.org/10.1159/000339653.
Ward BK, Carey JP, Minor LB. Superior canal dehiscence syndrome: lessons from the first 20 years. Front Neurol. 2017;8:177. PMID: 28503164; PMCID: PMC5408023. https://doi.org/10.3389/fneur.2017.00177.
Adams ME, Heidenreich KD, Kileny PR. Audiovestibular testing in patients with Meniere’s disease. Otolaryngol Clin North Am. 2010;43(5):995–1009. PMID: 20713239. https://doi.org/10.1016/j.otc.2010.05.008.
Zuniga MG, Janky KL, Nguyen KD, Welgampola MS, Carey JP. Ocular versus cervical VEMPs in the diagnosis of superior semicircular canal dehiscence syndrome. Otol Neurotol. 2013;34:121–6.
Basura GJ, Adams ME, Monfared A, Schwartz SR, Antonelli PJ, Burkard R, Bush ML, Bykowski J, Colandrea M, Derebery J, Kelly EA, Kerber KA, Koopman CF, Kuch AA, Marcolini E, McKinnon BJ, Ruckenstein MJ, Valenzuela CV, Vosooney A, Walsh SA, Nnacheta LC, Dhepyasuwan N, Buchanan EM. Clinical practice guideline: Ménière’s disease. Otolaryngol Head Neck Surg. 2020;162(2_suppl):S1–S55. PMID: 32267799. https://doi.org/10.1177/0194599820909438.
De Waele C, Huy PT, Diard JP, Freyss G, Vidal PP. Saccular dysfunction in Meniere’s disease. Am J Otol. 1999;20(2):223–32. PMID: 10100527.
Murofushi T, Shimizu K, Takegoshi H, Cheng PW. Diagnostic value of prolonged latencies in the vestibular evoked myogenic potential. Arch Otolaryngol Head Neck Surg. 2001;127(9):1069–72. PMID: 11556854. https://doi.org/10.1001/archotol.127.9.1069.
Rauch SD, Zhou G, Kujawa SG, Guinan JJ, Herrmann BS. Vestibular evoked myogenic potentials show altered tuning in patients with Ménière’s disease. Otol Neurotol. 2004;25(3):333–8. PMID: 15129114. https://doi.org/10.1097/00129492-200405000-00022.
Kharkheli E, Japaridze S, Kevanishvili Z, Oz I, Ozluoglu LN. Correlation between vestibular evoked myogenic potentials and disease progression in Ménière’s disease. ORL J Otorhinolaryngol Relat Spec. 2019;81(4):193–201. Epub 2019 Aug 7. PMID: 31390639. https://doi.org/10.1159/000496088.
Schuknecht HF. Endolymphatic hydrops: can it be controlled? Ann Otol Rhinol Laryngol. 1986;95(1 Pt 1):36–9. PMID: 3947002. https://doi.org/10.1177/000348948609500108.
Janky KL, Shepard N. Vestibular evoked myogenic potential (VEMP) testing: normative threshold response curves and effects of age. J Am Acad Audiol. 2009;20(8):514–22. PMID: 19764171; PMCID: PMC2749261. https://doi.org/10.3766/jaaa.20.8.6.
Iseli C, Gibson W. A comparison of three methods of using transtympanic electrocochleography for the diagnosis of Meniere’s disease: click summating potential measurements, tone burst summating potential amplitude measurements, and biasing of the summating potential using a low frequency tone. Acta Otolaryngol. 2010;130(1):95–101. PMID: 19396716. https://doi.org/10.3109/00016480902858899.
Ziylan F, Smeeing DP, Stegeman I, Thomeer HG. Click stimulus electrocochleography versus MRI with intratympanic contrast in Ménière’s disease: a systematic review. Otol Neurotol. 2016;37(5):421–7.
Arts HA, Adams ME, Telian SA, El-Kashlan H, Kileny PR. Reversible electrocochleographic abnormalities in superior canal dehiscence. Otol Neurotol. 2009;30(1):79–86. PMID: 19092559. https://doi.org/10.1097/MAO.0b013e31818d1b51.
Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, Nakata S, Katayama N, Ishida IM. Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope. 2007;117(3):415–20. PMID: 17279053. https://doi.org/10.1097/MLG.0b013e31802c300c.
Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Imaging of Ménière’s disease after intravenous administration of single-dose gadodiamide: utility of subtraction images with different inversion time. Magn Reson Med Sci. 2012;11(3):213–9. PMID: 23037568. https://doi.org/10.2463/mrms.11.213.
Naganawa S, Suzuki K, Nakamichi R, Bokura K, Yoshida T, Sone M, Homann G, Nakashima T, Ikeda M. Semi-quantification of endolymphatic size on MR imaging after intravenous injection of single-dose gadodiamide: comparison between two types of processing strategies. Magn Reson Med Sci. 2013;12(4):261–9. Epub 2013 Oct 29. PMID: 24172793. https://doi.org/10.2463/mrms.2013-0019.
Ho ML. Third window lesions. Neuroimaging Clin N Am. 2019;29(1):57–92. PMID: 30466645. https://doi.org/10.1016/j.nic.2018.09.005.
Browaeys P, Larson TL, Wong ML, Patel U. Can MRI replace CT in evaluating semicircular canal dehiscence? Am J Neuroradiol. 2013;34(7):1421–7.
Gioacchini FM, Alicandri-Ciufelli M, Kaleci S, Scarpa A, Cassandro E, Re M. Outcomes and complications in superior semicircular canal dehiscence surgery: a systematic review. Laryngoscope. 2016;126(5):1218–24. Epub 2015 Sep 15. PMID: 26371952. https://doi.org/10.1002/lary.25662.
Wackym PA, Balaban CD, Zhang P, Siker DA, Hundal JS. Third window syndrome: surgical management of cochlea-facial nerve dehiscence. Front Neurol. 2019;10:1281. PMID: 31920911; PMCID: PMC6923767. https://doi.org/10.3389/fneur.2019.01281.
Chemtob RA, Epprecht L, Reinshagen KL, Huber A, Caye-Thomasen P, Nakajima HH, Lee DJ. Utility of postoperative magnetic resonance imaging in patients who fail superior canal dehiscence surgery. Otol Neurotol. 2019;40(1):130–8. PMID: 30461526. https://doi.org/10.1097/MAO.0000000000002051.
Kim SH, Ko SH, Ahn SH, Hong JM, Lee WS. Significance of the development of the inner ear third window effect after endolymphatic sac surgery in Ménière disease patients. Laryngoscope. 2012;122(8):1838–43. Epub 2012 Jul 2. PMID: 22753085. https://doi.org/10.1002/lary.23332.
Eberhard KE, Chari DA, Nakajima HH, Klokker M, Cayé-Thomasen P, Lee DJ. Current trends, controversies, and future directions in the evaluation and management of superior canal dehiscence syndrome. Front Neurol. 2021;12:638574. PMID: 33889125; PMCID: PMC8055857. https://doi.org/10.3389/fneur.2021.638574.
Crowson MG, Patki A, Tucci DL. A systematic review of diuretics in the medical management of Ménière’s disease. Otolaryngol Head Neck Surg. 2016;154(5):824–34. Epub 2016 Mar 1. PMID: 26932948. https://doi.org/10.1177/0194599816630733.
Christopher LH, Wilkinson EP. Meniere's disease: medical management, rationale for vestibular preservation and suggested protocol in medical failure. Am J Otolaryngol. 2021;42(1):102817. Epub 2020 Nov 2. PMID: 33202330. https://doi.org/10.1016/j.amjoto.2020.102817.
Sepahdari AR, Vorasubin N, Ishiyama G, Ishiyama A. Endolymphatic hydrops reversal following acetazolamide therapy: demonstration with delayed intravenous contrast-enhanced 3D-FLAIR MRI. Am J Neuroradiol. 2016;37(1):151–4. Epub 2015 Sep 17. PMID: 26381561; PMCID: PMC7960214. https://doi.org/10.3174/ajnr.A4462.
Gürkov R, Flatz W, Keeser D, Strupp M, Ertl-Wagner B, Krause E. Effect of standard-dose Betahistine on endolymphatic hydrops: an MRI pilot study. Eur Arch Otorhinolaryngol. 2013;270(4):1231–5. Epub 2012 Jul 4. PMID: 22760844. https://doi.org/10.1007/s00405-012-2087-3.
Fiorino F, Mattellini B, Vento M, Mazzocchin L, Bianconi L, Pizzini FB. Does the intravenous administration of furosemide reduce endolymphatic hydrops? J Laryngol Otol. 2016;130(3):242–7. Epub 2016 Jan 14. PMID: 26763125. https://doi.org/10.1017/S0022215115003527.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Johnson, B.R., Semaan, M., Mowry, S., Rivas-Campo, A. (2022). Endolymphatic Hydrops . In: Gianoli, G.J., Thomson, P. (eds) Third Mobile Window Syndrome of the Inner Ear. Springer, Cham. https://doi.org/10.1007/978-3-031-16586-3_20
Download citation
DOI: https://doi.org/10.1007/978-3-031-16586-3_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-16585-6
Online ISBN: 978-3-031-16586-3
eBook Packages: MedicineMedicine (R0)